Eisai
4523.T
#2025
Rank
C$11.21 B
Marketcap
$39.79
Share price
-0.60%
Change (1 day)
-40.68%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

EPS for Eisai (4523.T)

EPS in 2023 (TTM): $2.95

According to Eisai's latest financial reports the company's current EPS (TTM) is $3.15. In 2022 the company made an earnings per share (EPS) of $2.32 a decrease over its 2021 EPS that were of $10.28.

EPS history for Eisai from 2009 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$2.9527.34%
2022$2.32-77.48%
2021$10.28-41.88%
2020$17.68-0.94%
2019$17.8552.59%
2018$11.70124.17%
2017$5.22-49.42%
2016$10.3237.08%
2015$7.53-11.75%
2014$8.53-3.23%
2013$8.82-18.56%
2012$10.82-15.51%
2011$12.81-3.75%
2010$13.31-1.36%
2009$13.50